Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern

NCT05168813 is registered in ClinicalTrials.gov with COVID-19 Prevention Network as lead sponsor.

NCT NCT05168813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05168813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern
Lead sponsor
COVID-19 Prevention Network
Phase
Phase 2/3
Overall status
Completed
Start date
December 1, 2021
Completion date
April 19, 2024
Enrollment
14,237 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, hiv infections, sars-cov-2 infection